Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Total 13F shares
-
46,220,859
-
Share change
-
-2,527,220
-
Total reported value
-
$267,610,930
-
Put/Call ratio
-
42%
-
Price per share
-
$5.79
-
Number of holders
-
136
-
Value change
-
-$15,551,476
-
Number of buys
-
52
-
Number of sells
-
62
Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q2 2016
As of 30 Jun 2016,
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,220,859 shares.
The largest 10 holders included
WASATCH ADVISORS INC, BAKER BROS. ADVISORS LP, Bank of New York Mellon Corp, FMR LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., STATE STREET CORP, BlackRock Institutional Trust Company, N.A., and Cormorant Asset Management, LLC.
This page lists
136
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.